Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
598.00    -6.00 (-0.99%)
Bid:
596.00
Ask:
598.00
Spread: 2.00 (0.336%)
Market Cap: £521.00m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Management Change

27 Apr 2012 07:00

RNS Number : 1795C
Victrex PLC
27 April 2012
 



27 April 2012

 

Victrex plc

 

Management Change

 

Victrex plc ("the Company") today announces that Hichem M'Saad has been appointed as Managing Director of our Invibio® Biomaterial Solutions business unit ("Invibio"). Hichem will join the Company on 18 June 2012, succeeding Michael Callahan, who will remain on the Invibio board as leader of the spine business.

 

Prior to joining Invibio Hichem's career included 14 years at Applied Materials Inc, most recently as Corporate Vice President and General Manager of their Silicon Sector Group. Hichem holds a PhD in Materials Science and Engineering from the Massachusetts Institute of Technology and has extensive commercial and technical experience globally, in both start-up and mature businesses.

David Hummel, Chief Executive said:

 

"I am delighted that Hichem is joining Invibio. His wealth of general management and commercial experience in technology driven businesses will enable him to lead Invibio into a new phase of growth and realise opportunities in new and existing market areas. He will be a valuable asset to both Invibio and the wider Victrex Group.

 

I would like to thank Michael for his contribution to the Invibio business since its launch in 2001. Michael has supported us through a period of significant growth, development and investment, and will continue to deliver Invibio's strategy in the spine business going forward."

 

 

Enquiries

 

Victrex plc

01253 898067

David Hummel, Chief Executive

Steve Barrow, Finance Director

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne

0203 128 8100

 

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a provider of innovative, high performance thermoplastic polymers. We work with customers and end users globally to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business unit ('VPS') focuses on our transport, industrial and electronics markets and our Invibio® Biomaterial Solutions business unit ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUGPCUPPGAQ
Date   Source Headline
25th Jul 20137:00 amRNSInterim Management Statement
17th Jul 20131:46 pmRNSDirector/PDMR Shareholding
2nd Jul 201310:54 amRNSHolding(s) in Company
2nd Jul 20137:39 amRNSDirector Declaration
28th Jun 20138:00 amRNSTotal Voting Rights
26th Jun 20139:35 amRNSHolding(s) in Company
25th Jun 201310:43 amRNSHolding(s) in Company
24th Jun 20132:33 pmRNSHolding(s) in Company
21st Jun 20139:13 amRNSHolding(s) in Company
18th Jun 20134:41 pmRNSDirector/PDMR Shareholding
7th Jun 201312:26 pmRNSHolding(s) in Company
5th Jun 20132:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20131:50 pmRNSBlocklisting Interim Review
31st May 20131:49 pmRNSTotal Voting Rights
28th May 20139:02 amRNSHolding(s) in Company
28th May 20137:00 amRNSHalf Yearly Report
20th May 20133:34 pmRNSHolding(s) in Company
17th May 20131:39 pmRNSDirector/PDMR Shareholding
16th May 201310:35 amRNSHolding(s) in Company
14th May 20139:58 amRNSHolding(s) in Company
30th Apr 20133:53 pmRNSTotal Voting Rights
24th Apr 20134:24 pmRNSHolding(s) in Company
22nd Apr 20134:14 pmRNSHolding(s) in Company
22nd Apr 20134:02 pmRNSHolding(s) in Company
17th Apr 20131:54 pmRNSDirector/PDMR Shareholding
16th Apr 20134:34 pmRNSHolding(s) in Company
9th Apr 20137:00 amRNSTrading Statement
3rd Apr 20133:01 pmRNSHolding(s) in Company
28th Mar 20133:00 pmRNSTotal Voting Rights
22nd Mar 20139:51 amRNSHolding(s) in Company
21st Mar 201310:25 amRNSHolding(s) in Company
20th Mar 201312:28 pmRNSDirector/PDMR Shareholding
13th Mar 201312:20 pmRNSHolding(s) in Company
28th Feb 20133:19 pmRNSTotal Voting Rights
28th Feb 20132:49 pmRNSDirector/PDMR Shareholding
27th Feb 201311:05 amRNSHolding(s) in Company
26th Feb 20139:32 amRNSHolding(s) in Company
20th Feb 201311:38 amRNSDirector/PDMR Shareholding
5th Feb 20134:24 pmRNSResult of AGM
5th Feb 20137:00 amRNSAGM and Interim Management Statement
4th Feb 201311:42 amRNSHolding(s) in Company
31st Jan 201312:47 pmRNSTotal Voting Rights
29th Jan 201312:46 pmRNSHolding(s) in Company
23rd Jan 201312:23 pmRNSHolding(s) in Company
17th Jan 20134:13 pmRNSDirector/PDMR Shareholding
8th Jan 201310:24 amRNSHolding(s) in Company
7th Jan 20132:40 pmRNSAnnual Information Update
7th Jan 20132:02 pmRNSAnnual Financial Report
7th Jan 201312:37 pmRNSHolding(s) in Company
28th Dec 201212:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.